Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer

Urology

Volumn 51, Issue 5, 1998, Pages 789-795

  Gheiler, Edward L ^a   Tefilli, Marcos V ^a   Tiguert, Rabi ^a   Grignon, David ^b   Cher, Michael L ^a   Sakr, Wael ^b   Pontes, J Edson ^a   Wood Jr, David P ^a  

^a HENRY FORD HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; SEMINAL VESICLE; SURVIVAL RATE; URINE INCONTINENCE;

ADENOCARCINOMA; AGED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEMINAL VESICLES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031745356     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00096-X     Document Type: Article

References (21)

1. Lee WR, Hanbon AL, Hanks GE. Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer the relationship between nadir level and disease-free survival . J Urol. 156:1996;450-453.
2. Zeitman AL, Coen JJ, Shipley WU, Willet CG, Efird JT. Radical radiation therapy in the management of prostatic adenocarcinoma the initial prostate specific antigen value as a predictor of treatment outcome . J Urol. 151:1994;640-645.
3. Scardino PT, Wheeler TM. Local control of prostate cancer with radiotherapy frequency and prognostic significance of positive results of postirradiation prostate biopsy . NCI Monogr. 7:1988;95-103.
4. Thompson IM, Rounder JB, Spence CR, Rodriguez FR. Salvage radical prostatectomy for adenocarcinoma of the prostate. Cancer. 61:1988;1464-1466.
5. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy outcome measured by serum specific antigen levels . J Urol. 153:1995;104-110.
6. Link P, Freiha FS. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology. 37:1991;189-192.
7. Ahlering TE, Lieskovsky G, Skinner DG. Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma. J Urol. 147:(3 Pt 2):1992;900-902.
8. Stein A, Smith RB, deKernion JB. Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of the prostate. Urology. 40:1992;197-200.
9. Pontes JE, Montie J, Klein E, Huben R. Salvage surgery for radiation failure in prostate cancer. Cancer. 71:(3 suppl):1993;976-980.
10. Yournes E, Hass GP, Montie JE, Smith JB, Powell IJ, Pontes JE. Value of preoperative PSA in predicting pathologic stage of patients undergoing salvage prostatectomy. Urology. 43:1994;22-25.
11. Lerner SE, Blute ML, Zincke H. Critical evaluation of salvage surgery for radiorecurrent/resistant prostate cancer. J Urol. 154:1995;1103-1109.
12. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD. Evaluating the radical prostatectomy specimen Part I . J Urol Pathol. 3:1995;355-358.
13. Kuban DA, el-Mahdi AM, Schellhammer PF. Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urology. 30:1987;420-426.
14. Robey EL, Schellhammer PF. Local failure after definitive therapy for prostate cancer. J Urol. 137:1987;613-619.
15. Miller BE, Ladaga LE, el-Mahdi AM, Schellhammer PF. Reevaluation of prostate biopsy after definitive radiation therapy. Urology. 41:1993;311-316.
16. Schellhammer PF, Kuban DA, el-Mahdi AM. Treatment of clinical local failure after radiation therapy for carcinoma of the prostate. J Urol. 150:1993;1851-1855.
17. Loening SA, Turner JW. Use of percutaneous transperineal 198A seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate. 23:1993;283-290.
18. Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW. Short term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology. 46:1995;676-680.
19. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N. Prostate specific antigen in diagnosis and treatment of adenocarcinoma of the prostate. J Urol. 141:1989;1076-1083.
20. Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. J Am Med Assoc. 269:1993;57-60.
21. Forman JD, Meetze K, Pontes E, Wood DP Jr, Shamsa F, Rana T, Porter AT. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol. 158:1997;1436-1439.